Source-grounded facts extracted from EXICURE, INC.'s SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
Han Eui Seok was appointed as Director at EXICURE, INC..
“To fill the newly created directorship resulting from the increase in the size of the Board, the Board appointed Han Eui Seok to serve as a Class III director of the Company, effective as of June 30, 2026.”
Go Jin Young was appointed as Director at EXICURE, INC..
“To fill the vacancy created by the resignation of Ham Jung Kyu, the Board appointed Go Jin Young to serve as a Class III director of the Company, effective as of June 30, 2026.”
Ham Jung Kyu resigned as Director at EXICURE, INC..
“On June 24, 2026, Ham Jung Kyu resigned from the Board of Directors (the “Board”) of Exicure, Inc. (the “Company”), effective as of June 30, 2026.”
EXICURE, INC. reported the year ended December 31, 2025 results: net income $4.9 million.
“The Company had a net loss of $4.9 million for the year ended December 31, 2025, compared to a net loss of $9.7 million for the year ended December 31, 2024.”
EXICURE, INC. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).
“May 21, 2025, Exicure, Inc. (the “Company”) received a delinquency notification letter (the “Letter”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that due to the delay in filing the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2025 (the “Form 10-Q”), the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1), which requires listed companies to timely file all periodic financial reports with the Securities and Exchange Commission (the “SEC”). The Letter states that, the Company has 60 calendar da”
EXICURE, INC. engaged CBIZ CPAs P.C. as its auditor.
“On April 10, 2025, Marcum resigned as the Company’s independent registered public accounting firm, and CBIZ CPAs was engaged to serve as the independent registered public accounting firm of the Company for the year ending December 31, 2025, effective immediately.”
Marcum LLP resigned as auditor of EXICURE, INC..
“On April 10, 2025, Marcum resigned as the Company’s independent registered public accounting firm, and CBIZ CPAs was engaged to serve as the independent registered public accounting firm of the Company for the year ending December 31, 2025, effective immediately.”
Paul Kang resigned as Director at EXICURE, INC..
“In conjunction with the execution of this consulting agreement, Mr. Kang resigned from the Board for personal reasons, effective as of March 3, 2025.”
Jiyoung Hwang resigned as Director at EXICURE, INC..
“On February 28, 2025, Jiyoung Hwang resigned from the Board of Directors (the “Board”) of Exicure, Inc. (the “Company”) for personal reasons, effective immediately as of such date.”
Minwoo Kang was appointed as Chair of the Audit Committee at EXICURE, INC..
“effective January 1, 2005, Mr. Choi and Mr. Kang have been appointed to the Audit Committee of the Board, with Mr. Kang serving as the Chair of the Audit Committee.”
Minwoo Kang was appointed as Director at EXICURE, INC..
“the Company announced the appointment of Chang Keun Choi and Minwoo Kang to the Company's Board of Directors (the 'Board'), effective December 19, 2024.”
Chang Keun Choi was appointed as Director at EXICURE, INC..
“the Company announced the appointment of Chang Keun Choi and Minwoo Kang to the Company's Board of Directors (the 'Board'), effective December 19, 2024.”
Eui Yull Hwang resigned as Director at EXICURE, INC..
“On November 21, 2024, Eui Yull Hwang resigned from the Board for personal reasons, effective immediately as of such date.”
Hojoon Lee resigned as Director at EXICURE, INC..
“On November 21, 2024, Hojoon Lee resigned from the Board for personal reasons, effective immediately as of such date.”
Seung Ik Baik was appointed as Class III Director at EXICURE, INC..
“on November 21, 2024, the Board of Directors (the "Board’) of the Company appointed Andy Yoo and Seung Ik Baik to the Board.”
Andy Yoo was appointed as Chief Restructuring Officer at EXICURE, INC..
“The Board also appointed Mr. Yoo as the Chief Restructuring Officer of the Company and entered into an employment agreement with Mr. Yoo effective November 21, 2024.”
Andy Yoo was appointed as Class I Director at EXICURE, INC..
“on November 21, 2024, the Board of Directors (the "Board’) of the Company appointed Andy Yoo and Seung Ik Baik to the Board.”
EXICURE, INC. completed a disposition involving Flashpoint Therapeutics, Inc. for $1.5 million (closed 2024-09-27).
“programs, and clinical assets (the “Assets”) to the Purchaser as described in the Purchase Agreement (the “ Transaction ”). The Company will receive gross proceeds of $1.5 million from the sale of the Assets. The Company plans to support the Purchaser as the Purchaser pursues development and licenses components of the Assets to third parties and will”
Eui Yull Hwang was appointed as Independent Director at EXICURE, INC..
“On September 26, 2024, the Board increased the size of the Board from six directors to seven directors and appointed Eui Yull Hwang as an independent director to fill the vacancy.”
EXICURE, INC. reported third quarter 2023 results: net income Net loss of $5.3 million.
“Exicure, Inc. Reports Third Quarter 2023 Financial Results”
EXICURE, INC. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).
“April 17, 2024, Exicure, Inc. (the “ Company ”) received a delinquency notification letter (the “ Letter ”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“ Nasdaq ”) notifying the Company that since it has not yet filed its Form 10-K for the year ended December 31, 2023 the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1), which requires listed companies to timely file all periodic financial reports with the U.S. Securities and Exchange Commission. The Letter states that the Company must submit an update to its original plan to regain compliance wit”
EXICURE, INC. received a nasdaq deficiency notice notice regarding shareholders (rules 5620(a)).
“January 11, 2024, Exicure, Inc. (the “ Company ”) received a delinquency notification letter (the “ Letter ”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“ Nasdaq ”) notifying the Company that since it has not yet held an annual meeting of shareholders within twelve months of the end of the Company’s December 31, 2022 fiscal year end, the Company is not in compliance with Nasdaq Listing Rule 5620(a), which requires listed companies to hold an annual meeting of shareholders. The Letter states that, the Company has 45 calendar days to submit a plan addressing how i”
EXICURE, INC. reported that prior financial statements should not be relied upon.
“Therefore, the financial statements for the Affected Periods should no longer be relied upon and are to be restated. Approximately $0.6 million of expenses in the first quarter of 2023 will be corrected from research and development into general and administrative. These expenses related to separation pay from former R&D employees and legal costs associated with our intellectual property. Approximately $0.9 million of expenses in the second quarter of 2023 will be corrected from research and development into general and administrative. These expenses primarily related to the office lease, depreciation of scientific equipment, legal costs associated with our intellectual property, and other wind down costs. The corrections do not impact our net loss for the periods. The Company expects to file restated financial statements for the Affected Periods on two separate Form 10-Q/A's as soon as”
EXICURE, INC. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).
“November 22, 2023, Exicure, Inc. (the “ Company ”) received a delinquency notification letter (the “ Letter ”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“ Nasdaq ”) notifying the Company that due to the delay in filing the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2023 (the “ Form 10-Q ”), the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1), which requires listed companies to timely file all periodic financial reports with the Securities and Exchange Commission (the “ SEC ”). The Letter states that, the Company”
Minhee Eom was appointed as Director (Class II) at EXICURE, INC..
“The Board appointed Minhee Eom to the Board, effective September 26, 2023.”
EXICURE, INC. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).
“September 13, 2023, Exicure, Inc. (the “Company”) received a letter (the “Notice”) from the staff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, for the previous 30 consecutive business days, the bid price for the Company’s common stock had closed below the minimum $1.00 per share requirement for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2) (the “Bid Price Requirement”). In accordance with Nasdaq Listing Rule 5810(c)(3)(A) (the “Compliance Period Rule”), the Company has been provided an initial period of 180 calendar d”
Hojoon Lee was appointed as Director at EXICURE, INC..
“The Board appointed Hyuk Joon (Raymond) Ko, Dongho Lee and Hojoon Lee to the Board, effective August 21, 2023.”
Dongho Lee was appointed as Director at EXICURE, INC..
“The Board appointed Hyuk Joon (Raymond) Ko, Dongho Lee and Hojoon Lee to the Board, effective August 21, 2023.”
Hyuk Joon (Raymond) Ko was appointed as Director at EXICURE, INC..
“The Board appointed Hyuk Joon (Raymond) Ko, Dongho Lee and Hojoon Lee to the Board, effective August 21, 2023.”
Jiyoung Hwang was appointed as Chief Financial Officer and Secretary at EXICURE, INC..
“and Jiyoung Hwang as the Chief Financial Officer and Secretary of the Company.”
Paul Kang was appointed as Chief Executive Officer and President at EXICURE, INC..
“On August 21, 2023, in connection with Mr. Kim’s resignation, the Board appointed Paul Kang as the Chief Executive Officer and President of the Company”
Jung Sang (Michael) Kim resigned as Chief Executive Officer at EXICURE, INC..
“In connection with his resignation from the Board, Mr. Kim also resigned as the Chief Executive Officer, Chief Financial Officer, President and Secretary of the Company.”
Jung Sang (Michael) Kim resigned as Director at EXICURE, INC..
“On August 18, 2023, Jung Sang (Michael) Kim resigned from the Board for personal reasons, effective immediately as of such date.”
Changil Ahn resigned as Director at EXICURE, INC..
“On August 18, 2023, Changil Ahn resigned from the Board of Directors (the “ Board ”) and the Audit Committee for personal reasons, effective immediately as of such date.”
EXICURE, INC. reported the quarter ended June 30, 2023 results: net income $5.8 million.
“The Company had a net loss of $5.8 million for the quarter ended June 30, 2023, as compared to a net loss of $7.5 million for the quarter ended June 30, 2022.”
Cheolho Jo resigned as Director at EXICURE, INC..
“On August 1, 2023, Cheolho Jo resigned from the Board and the Audit Committee, effective immediately as of such date.”
EXICURE, INC. reported the quarter ended March 31, 2023 results: net income $4.4 million.
“Net Loss: The Company had a net loss of $4.4 million for the quarter ended March 31, 2023, as compared to a net loss of $8.3 million for the quarter ended March 31, 2022.”
EXICURE, INC. engaged Marcum LLP as its auditor.
“(the “ Company ”) engaged Marcum LLP (“ Marcum ”) to act as the Company’s independent registered public accounting firm, effective immediately, which was approved by the Audit Committee of the Board of Directors.”
Sarah Longoria resigned as Chief Human Resources and Compliance Officer at EXICURE, INC..
“Sarah Longoria has resigned as the Chief Human Resources and Compliance Officer, effective as of May 27, 2023.”
Joshua Miller was appointed as Chief Accounting Officer at EXICURE, INC..
“As previously disclosed, Joshua Miller has been appointed to Chief Accounting Officer by the Board of Directors (the “Board”) and in connection with his appointment, Exicure, Inc. (the “Company”) entered into an amended and restated employment agreement.”
EXICURE, INC. received a nasdaq noncompliance notice notice regarding late filing (rules 5250(c)(1)).
“May 17, 2023, Exicure, Inc. (the “ Company ”) received a delinquency notification letter (the “ Letter ”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“ Nasdaq ”) notifying the Company that due to the delay in filing the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2023 (the “ Form 10-Q ”), the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1), which requires listed companies to timely file all periodic financial reports with the Securities and Exchange Commission (the “ SEC ”). The Letter states that, the Company has 60 c”
EXICURE, INC. entered into Subscription Agreement with Cyworld Z Co., Ltd. valued at USD $1 million (effective 2023-05-16).
“On May 16, 2023, Exicure, Inc. (the “ Company ”) entered into a subscription agreement (the “ Subscription Agreement ”) with Cyworld Z Co., Ltd., (“ Cyworld Z ”).”
KPMG LLP resigned as auditor of EXICURE, INC..
“(a) Resignation of Independent Registered Public Accounting Firm On May 8, 2023, KPMG LLP (“ KPMG ”) resigned as the independent registered public accounting firm of the Company and subsidiary, effective immediately.”
EXICURE, INC. received a nasdaq noncompliance notice notice regarding audit committee (rules 5605, 5605(c)(4)).
“May 10, 2023, Exicure, Inc. (the “ Company ”) received notice from The Nasdaq Stock Market LLC (“ Nasdaq ”) that the Company is no longer in compliance with Nasdaq’s audit committee requirements as set forth in Nasdaq Listing Rule 5605 as a result of the previously disclosed resignation of Hyukku Lee, effective May 3, 2023 . Nasdaq Rule 5605 requires the audit committee of the board of directors to be comprised of at least three independent directors (the “ Listing Requirement for Audit Committee ”). Pursuant to Nasdaq Listing Rule 5605(c)(4), the Company is entitled to a cure period to regain”
EXICURE, INC. entered into Subscription Agreement with Cyworld Z Co., Ltd. valued at USD $1 million (effective 2023-05-03).
“As previously disclosed, on May 3, 2023, Exicure, Inc. (the “ Company ”) entered into a subscription agreement (the “ Subscription Agreement ”) with Cyworld Z Co., Ltd., (“ Cyworld Z ”).”
EXICURE, INC. received a nasdaq deficiency notice notice regarding other.
“May 5, 2023, the Company notified the Listing Qualifications Department of The Nasdaq Stock Market LLC (“ Nasdaq ”) that as a result of Hyukku Lee from the Company’s board of directors (the “ Board ”) (as described below in”
Joshua Miller was appointed as Chief Accounting Officer at EXICURE, INC..
“On May 3, 2023, the Board approved the appointment of Joshua Miller to Chief Accounting Officer.”
Hyukku Lee resigned as Class II Director at EXICURE, INC..
“On May 3, 2023, Hyukku Lee resigned from the Board as a Class II Director, effective immediately as of such date.”
Jiyoung Hwang was appointed as Class I Director at EXICURE, INC..
“Jiyoung Hwang was appointed to fill the Class I Director vacancy”
Seung Shoo Shin resigned as Class II Director at EXICURE, INC..
“Mr. Schroff and Seung Shoo Shin resigned from the Board as Class I and Class II Directors, respectively.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.